BioNTech SE and Pfizer (PFE) recently received a positive recommendation from the European Medicines Agency for marketing ...

Pfizer is cutting costs, growing its core business, and trading at a deep discount despite looming patent losses and COVID ...

In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine was viable.

If we take a look at Pfizer’s top products for 2024, we can observe that the sales from their COVID vaccine, Comirnaty, dropped more than 50% vs. 2023 due to a decrease in vaccinations globally ...

Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.

Pfizer (PFE) announced it does not anticipate significant changes to U.S. vaccine policy under the incoming Trump administration, despite vaccine skeptic Robert F. Kennedy Jr.’s nomination to ...

Pharmaceutical giant Pfizer recently shared its plans to revive vaccine awareness in Mexico and become a key vaccine supplier ...

Pfizer (PFE), a global pharmaceutical giant that was once a pandemic darling, is now facing turbulence. Following a period of extraordinary vaccine-driven revenue, the company now faces a more ...

The settlements will see BioNTech pay $791.5 million to NIH and $467 million to Penn, with Pfizer , its vaccine partner, ... adding uncertainty to BioNTech’s growth strategy.

Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in ...

Vaccine Development Insights. Scientific Foundation Moderna and Pfizer-BioNTech vaccines are revolutionary in the field of immunology, utilizing messenger RNA (mRNA) technology to instruct cells ...